Stonepine Capital Management, LLC Quant / Systematic

CIK: 0001440771 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 12, 2021

Total Value ($000): $219,763 (100.0% shares, 0.0% debt)

Holdings (31)

AMRYT PHARMA PLC - SPNR ADR 31.8%
Value ($000) $69,882 Shares 5,801,748 Est. Cost $12.69 Unrealized
CTI BIOPHARMA CORP 10.7%
Value ($000) $23,495 Shares 7,964,329 Est. Cost $2.50 Unrealized
ADAMAS PHARMACEUTICALS INC 8.7%
Value ($000) $19,222 Shares 3,914,938 Est. Cost $4.82 Unrealized
GLPG GALAPAGOS NV-SPON ADR 5.8%
Value ($000) $12,848 Shares 244,205 Est. Cost $52.61 Unrealized
OVID OVID THERAPEUTICS INC 5.0%
Value ($000) $10,930 Shares 3,252,892 Est. Cost $3.45 Unrealized +5.8%
CATALYST BIOSCIENCES INC 4.9%
Value ($000) $10,830 Shares 2,635,014 Est. Cost $4.78 Unrealized
STRONGBRIDGE BIOPHARMA PLC 4.2%
Value ($000) $9,159 Shares 4,489,687 Est. Cost $2.64 Unrealized
APOLLO ENDOSURGERY INC 3.8%
Value ($000) $8,264 Shares 912,125 Est. Cost $4.82 Unrealized
AFFIMED NV 3.3%
Value ($000) $7,178 Shares 1,161,466 Est. Cost $6.74 Unrealized
GAMIDA CELL LTD 3.1%
Value ($000) $6,759 Shares 1,724,201 Est. Cost $4.84 Unrealized
XGN EXAGEN INC 2.4%
Value ($000) $5,313 Shares 390,637 Est. Cost $15.26 Unrealized -12.9%
CELC CELCUITY INC 2.4%
Value ($000) $5,304 Shares 294,692 Est. Cost $20.31 Unrealized +4.4%
YUMANITY THERAPEUTICS INC 2.3%
Value ($000) $4,971 Shares 481,692 Est. Cost $15.79 Unrealized
ATYR ATYR PHARMA INC 1.7%
Value ($000) $3,728 Shares 410,535 Est. Cost $5.98 Unrealized 0.0%
KALV KALVISTA PHARMACEUTICALS INC 1.6%
Value ($000) $3,490 Shares 200,000 Est. Cost $26.28 Unrealized -22.9%
SYNLOGIC INC 1.4%
Value ($000) $3,050 Shares 1,000,000 Est. Cost $3.05 Unrealized
ANGION BIOMEDICA CORP 1.2%
Value ($000) $2,737 Shares 280,183 Est. Cost $14.79 Unrealized
EOLS EVOLUS INC 1.0%
Value ($000) $2,286 Shares 300,000 Est. Cost $10.34 Unrealized 0.0%
AVALO THERAPEUTICS INC 0.8%
Value ($000) $1,853 Shares 850,000 Est. Cost $2.18 Unrealized
CIDARA THERAPEUTICS INC 0.8%
Value ($000) $1,754 Shares 782,817 Est. Cost $2.02 Unrealized
XOMA XOMA CORP 0.8%
Value ($000) $1,696 Shares 68,542 Est. Cost $20.24 Unrealized +45.5%
LEAP THERAPEUTICS INC 0.5%
Value ($000) $1,003 Shares 250,000 Est. Cost $4.01 Unrealized
ANTARES PHARMA INC 0.4%
Value ($000) $961 Shares 264,100 Est. Cost $3.64 Unrealized
EYPT EYEPOINT PHARMACEUTICALS INC 0.4%
Value ($000) $839 Shares 80,537 Est. Cost $11.25 Unrealized -15.2%
DMAC DIAMEDICA THERAPEUTICS INC 0.3%
Value ($000) $665 Shares 165,775 Est. Cost $4.96 Unrealized -22.8%
CONFORMIS INC 0.3%
Value ($000) $648 Shares 486,982 Est. Cost $1.04 Unrealized
NEUBASE THERAPEUTICS INC 0.2%
Value ($000) $396 Shares 109,742 Est. Cost $3.94 Unrealized
IMUX IMMUNIC INC 0.1%
Value ($000) $198 Shares 22,409 Est. Cost $9.84 Unrealized 0.0%
CONTRAFECT CORP 0.1%
Value ($000) $139 Shares 34,413 Est. Cost $4.80 Unrealized
SEASPINE HOLDINGS CORP 0.1%
Value ($000) $131 Shares 8,349 Est. Cost $15.69 Unrealized
SCYX SCYNEXIS INC 0.0%
Value ($000) $34 Shares 6,327 Est. Cost $6.57 Unrealized -0.3%